Caricamento quotazioni...
Previsioni
| Acquista |
1 |
| Mantieni |
0 |
| Vendi |
0 |
Discussioni nella community
- Verkaufte oder ausgebuchte Aktien kommen immer wieder
Bereits verkaufte und oder gelöschte Aktien die aus Spin-Offs oder Abspaltungen stammen werden immer wieder eingebucht. Haleon und Glaxosmithcline habe ich heute zum 8. Mal gelöscht. Natürlich wird…
Wichtel IV in Schnack 1 3 - Fehlerhafte Einbuchung der Haleon PLC
Mir wurde kürzlich die Haleon PLC (A3DNZQ) automatisiert ins Depot gebucht. Nach dem Split von der GSK, habe ich diese aber sofort verkauft. Nun kann ich die Einbuchung in Parqet nicht löschen?…
D Daniel II in Schnack
0 2 - Haleon Einbuchung auf einmal wieder da?
Hi! Mir wurden durch die Beteiligung an GSK in 2022 ein paar Haleon Aktien ins Portfolio gespült, welche ich dann im Anschluss verkauft habe. Alles auch in Parqet soweit eingepflegt. Ich habe nun…
T Timo II in Schnack
0 4 - (✅) Fehler bei GSK
Hallo, bei GSK wurde vor kurzem ein reverse split durchgeführt. Seit dem stimmen die Beträge in meinem Portfolio nicht mehr… Beim Split von Tesla war allerdings alles in Ordnung Danke für eine…
Andreas Kappes V in Schnack
0 5 - (✅) GSK Abspaltung Haleon GB00BMX86B70 nicht unterstützt
Servus, kann die Einbuchung nicht vornehmen, da GB00BMX86B70 nicht unterstützt wird.
Sven III in Schnack 6 16
Notizie Vai al feed delle notizie
Haleon cuts revenue forecast after weak cold-season quarter, shares fall
Haleon lowered its expectation for organic revenue growth in 2026 to around 2.5% (previously 3–5%) after a weak third quarter. The shares fell nearly 12% even though the adjusted operating profit outlook remained unchanged and a £500 million share buyback was announced. Headwinds included a mild cold season in North America, an export ban for Centrum in China due to a changed raw-material classification, and an accelerated distribution model in Brazil that is expected to cause Q4 sales losses of £15–20 million. A bright spot was the oral care business, with sales up 8.8%, and emerging markets sales rose 5.1%. » Altro su wiwo.de
Haleon publishes latest figures on share capital and voting rights
Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » Altro su de.investing.com
Haleon appoints new members to committees
Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » Altro su de.investing.com
Haleon stock delivers 12.16 percent return over three years
An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » Altro su finanzen.net
Haleon stock delivers 9.56 percent return in one year
An investment of £100 in Haleon shares a year ago would be worth £109.56 today, representing a return of 9.56 percent. The stock was trading at £3.32 a year ago and is currently at £3.63. Haleon's market capitalization currently stands at £32.66 billion. » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giugno 2025 | YoY |
|---|---|---|
| Ricavi | 3,19 Mld | - |
| Utile lordo | 2,06 Mld | - |
| Utile netto | 469,43 Mln | - |
| EBITDA | 811,32 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 36,47 Mld € |
Numero di azioni | 8,78 Mld |
Massimo/minimo a 52 settimane | 5,24 € - 3,78 € |
Rendimento da dividendo | 2,01% |
Dividendi TTM | 0,0842 € |
Beta | 0,24 |
Rapporto P/E | 19,08 |
Rapporto PEG | 3,24 |
Rapporto P/B | 1,89 |
Rapporto P/S | 2,73 |
Profilo aziendale
Haleon plc si occupa di ricerca e sviluppo, produzione e vendita di vari prodotti per la salute dei consumatori in Nord America, Europa, Medio Oriente, Africa, America Latina e Asia-Pacifico. L'azienda offre prodotti per la salute orale terapeutica, il sollievo dal dolore, la salute respiratoria, la salute digestiva e altri prodotti, nonché vitamine, minerali e integratori alimentari. Il suo portafoglio di marchi comprende Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax e Centrum. La società era precedentemente nota come DRVW 2022 plc e ha cambiato denominazione in Haleon plc nel febbraio 2022. Haleon plc è stata costituita nel 2021 ed ha sede a Brentford, nel Regno Unito.
| Nome | Haleon PLC |
| CEO | Brian James McNamara |
| Sede centrale | Weybridge,
su Regno Unito |
| Sito web | |
| Settore | Beni di prima necessità |
| Industria | Prodotti per la cura della persona |
| Quotazione in borsa | 18/07/2022 |
| Dipendenti | 24.561 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Pnk | HLNCF |
London Stock Exchange | HLN.L |
XETRA | H6D0.DE |
Frankfurt | H6D0.F |
Düsseldorf | H6D0.DU |
Hamburg | H6D0.HM |
London | HLN.L |
München | H6D0.MU |